GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a substantial shift in how we approach diabetes mellitus . These new drugs function to stimulating the body’s natural GLP-1 substance , https://mnobookmarks.com/story21606084/glp-1-a-significant-breakthrough-in-blood-sugar-management